BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9112178)

  • 1. Increase in aqueous humor production following D1 receptors activation by means of ibopamine.
    Virno M; Taverniti L; De Gregorio F; Sedran L; Longo F
    Int Ophthalmol; 1996-1997; 20(1-3):141-6. PubMed ID: 9112178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ibopamine eye drops on intraocular pressure and aqueous humor flow in healthy volunteers and patients with open-angle glaucoma.
    Azevedo H; Ciarniello MG; Rosignoli MT; Dionisio P; Cunha-Vaz J
    Eur J Ophthalmol; 2003 May; 13(4):370-6. PubMed ID: 12872794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical ibopamine and corticosteroids in the treatment of post-surgery ocular hypotony.
    Virno M; De Gregorio F; Pannarale L; Arrico L
    Int Ophthalmol; 1996-1997; 20(1-3):147-50. PubMed ID: 9112179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ibopamine: D1-dopaminergic agonist in the diagnosis of glaucoma.
    Virno M; Sampaolesi R; Pecori Giraldi J; De Gregorio F; Taloni M; Brusini P; Di Staso S; Stecchi G
    J Glaucoma; 2013 Jan; 22(1):5-9. PubMed ID: 21946546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ibopamine on aqueous humor production in normotensive humans.
    McLaren JW; Herman DC; Brubaker RF; Nau CB; Wayman LL; Ciarniello MG; Rosignoli MT; Dionisio P
    Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4853-8. PubMed ID: 14578408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibopamine in glaucoma diagnostics: a new pharmacological provocative test.
    De Gregorio F; Pecori Giraldi J; Pannarale L; Saccucci S; Virno M
    Int Ophthalmol; 1996-1997; 20(1-3):151-5. PubMed ID: 9112180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparison of topical ibopamine 2% with tonography to identify the outflow resistance in eyes with ocular hypertension.
    Hepsen IF; Yilmaz H; Keskin UC
    Ophthalmic Res; 2005; 37(1):17-22. PubMed ID: 15627837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latanoprost and the ibopamine test: a year's experience.
    Pecori Giraldi J; Mollicone A; Seguto D; Simeone L; Zaccara F
    Acta Ophthalmol Scand Suppl; 2000; (232):70-1. PubMed ID: 11334015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibopamine test in healthy and glaucomatous eyes: tonometric and pupillographic study.
    Brogliatti B; Boles Carenini A; Bogetto C; Vadalà G; Grignolo FM; Boles Carenini B
    Acta Ophthalmol Scand Suppl; 2000; (232):13-4. PubMed ID: 11235513
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of 2% ibopamine eye drops on the intraocular pressure and pupil motility of patients with open-angle glaucoma.
    Giuffrè I; Taverniti L; Di Staso S
    Eur J Ophthalmol; 2004; 14(6):508-13. PubMed ID: 15638100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ibopamine challenge test can be used to differentiate glaucoma suspects from glaucoma patients.
    Ullrich K; Craig JE; Landers J
    Clin Exp Ophthalmol; 2014; 42(4):342-6. PubMed ID: 24034130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular pressure increase by ibopamine discloses aqueous humour outflow changes in normal tension eyes.
    Virno M; De Gregorio F; Pannarale MR
    Acta Ophthalmol Scand Suppl; 2000; (232):12-3. PubMed ID: 11235512
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison between the 1% and 2% ibopamine provocative test in primary open-angle glaucoma patients: sensitivity, specificity and tolerability.
    Magacho L; Costa ML; Dessimoni A; de Avila MP
    Arq Bras Oftalmol; 2006; 69(5):695-9. PubMed ID: 17187138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ibopamine challenge testing differentiates glaucoma suspect, stable glaucoma and progressive glaucoma cases.
    Landers J; Ullrich K; Craig JE
    Clin Exp Ophthalmol; 2015 Dec; 43(9):808-14. PubMed ID: 26140527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine, dopaminergic drugs and ocular hypertension.
    Virno M; Gazzaniga A; Taverniti L; Pecori Giraldi J; De Gregorio F
    Int Ophthalmol; 1992 Sep; 16(4-5):349-53. PubMed ID: 1358853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibopamine provocative test and glaucoma: consideration of factors that may influence the examination.
    Magacho L; Lima FE; Costa ML; Fayad FA; Guimarães NL; Avila MP
    Curr Eye Res; 2004 Mar; 28(3):189-93. PubMed ID: 14977521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between ocular hypertension induced by ibopamine and perimetric defect in primary open-angle glaucoma.
    De Gregorio F; Pecori-Giraldi J; De Stefano C; Virno M
    Eur J Ophthalmol; 1997; 7(2):152-5. PubMed ID: 9243219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of the effects of 2% ibopamine, 10% phenylephrine, and 1% tropicamide on the anterior segment.
    Marchini G; Babighian S; Tosi R; Perfetti S; Bonomi L
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):281-9. PubMed ID: 12506086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation.
    Rosenberg LF; Krupin T; Tang LQ; Hong PH; Ruderman JM
    Ophthalmology; 1998 Jan; 105(1):88-92; discussion 92-3. PubMed ID: 9442783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 8-iso prostaglandin E2 on aqueous humor dynamics in monkeys.
    Wang RF; Lee PY; Mittag TW; Podos SM; Serle JB; Becker B
    Arch Ophthalmol; 1998 Sep; 116(9):1213-6. PubMed ID: 9747682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.